Clinical Trials Directory

Trials / Completed

CompletedNCT01566318

Depression Agency-Based Collaboration

Depression Agency-Based Collaborative (Depression ABC)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Seniors who receive supportive services face a variety of psychosocial vulnerabilities that put them at risk for depression. One group with very high risk is older adults receiving aging services through Medicaid waiver programs. This 3-year research uses a randomized controlled clinical trial to assess the effectiveness of brief behavioral therapies (problem solving therapy \[PST\] and Brief Behavioral Therapy for Insomnia \[BBTI\]) to prevent depression in seniors receiving aging services.

Detailed description

The research will determine (i) if a course of problem solving therapy (PST) and Brief Behavioral Therapy for Insomnia (BBTI), with boosters, reduces incidence of major depressive episodes over 12 months relative to usual care, and (ii) the extent to which behavioral therapies achieve these effects through enhancement of protective factors, such as greater self-efficacy, better targeting of services to address needs, and greater control over home environments. Periodic blood draws will be used to assess biosignatures of depression. Guiding our investigations of pharmacogenetics, inflammation, and proteomics are synergistic interactions among the serotonergic system, the HPA axis, systemic inflammation, growth factors such as brain derived neuro-trophic factor (BDNF), psychosocial stressors, and vascular co-morbidity. Genetic variation in vasopressin receptors, potentially involved in both cardiovascular risk and social attachment, is also associated with recurrence of depression. Similarly, genetic variation in inflammation may influence antidepressant response and medical co-morbidity.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProblem-Solving Therapy6-8 sessions over 8 weeks, with booster

Timeline

Start date
2012-03-01
Primary completion
2016-02-01
Completion
2016-06-01
First posted
2012-03-29
Last updated
2016-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01566318. Inclusion in this directory is not an endorsement.